Results about: immune system

TLK protein inhibition activates the innate immune system

These proteins are a potential therapeutic target for enhancing the effect of some cancer treatments.

Inhibition of TLK proteins triggers the Alternative Lengthening of Telomeres pathway, a common process in some of the most aggressive types of cancer, such as glioblastoma.

The study, performed by the Genomic Instability and Cancer Laboratory at IRB Barcelona, has been published in the journal Cell Reports.

The immune system of the alpaca reveals a potential treatment for cancer

A study done at IRB Barcelona and the Vrije Universiteit Brussel identifies camelid nanobodies able to block EGF, a protein that is abundant in tumour cells and that helps them to proliferate.

Eduard Batlle receives a distinction from the Fundació Internacional Olof Palme

The IRB Barcelona scientist and head of the Colorectal Cancer Lab has been awarded the Olof Palme Medal in recognition of his recent discovery regarding the treatment of advanced-stage colon tumors with immunotherapy.

IRB Barcelona paves the way to the use of immunotherapy to treat aggressive colon tumours and their metastasis

A team headed by ICREA researcher Eduard Batlle discovers that immune system-stimulating treatments combined with a TGF-beta inhibitor are effective against colon cancer.

The researchers developed a mouse model that mimics advanced human colon cancer. This model has allowed them to study the immune system response for the first time.